Comparison between Evoq Remedies IPO and Swaraj Suiting IPO.
IPO Details
Evoq Remedies IPO is a SME Fixed Price IPO proposed to list at BSE SME while Swaraj Suiting IPO is a SME Fixed Price proposed to list at NSE SME.
Issue Size and Price
The total issue size of Evoq Remedies IPO is up to ₹9.23 Cr whereas the issue size of the Swaraj Suiting IPO is up to ₹10.15 Cr. The final issue price of Evoq Remedies IPO is ₹27.00 per share and of Swaraj Suiting IPO is ₹56.00 per share.
IPO Timetable
Evoq Remedies IPO opens on Mar 17, 2022, while Swaraj Suiting IPO opens on Mar 15, 2022. The closing date of Evoq Remedies IPO and Swaraj Suiting IPO is Mar 22, 2022, and Mar 17, 2022, respectively.
| | Evoq Remedies IPO | Swaraj Suiting IPO |
|---|
| Issue Open | Mar 17, 2022 | Mar 15, 2022 |
| Issue Close | Mar 22, 2022 | Mar 17, 2022 |
| Basis Of Allotment (Tentative) | Mar 25, 2022 | Mar 23, 2022 |
| Initiation of Refunds (Tentative) | Mar 28, 2022 | Mar 24, 2022 |
| Credit of Share (Tentative) | Mar 29, 2022 | Mar 25, 2022 |
| Listing date (Tentative) | Mar 30, 2022 | Mar 28, 2022 |
Financials & KPIs
Evoq Remedies IPO P/E ratio is 33.75, as compared to Swaraj Suiting IPO P/E ratio of 10.55.
Shares Offered
In the Evoq Remedies IPO Retail Individual Investors (RII) are offered 17,10,000 shares while in Swaraj Suiting IPO retail investors are offered 17,10,000 shares. Qualified Institutional Buyers (QIB) are offered in Evoq Remedies IPO and in Swaraj Suiting IPO.
| | Evoq Remedies IPO | Swaraj Suiting IPO |
|---|
| Market Maker Reservation | 1,80,000 shares | 96,000 shares |
| NII | 17,10,000 shares | 9,04,000 shares |
| RII | 17,10,000 shares | 9,08,000 shares |
| Total | 34,20,000 shares | 18,12,000 shares |
Bids Received (Subscription)
Evoq Remedies IPO subscribed 1.67x in total, whereas Swaraj Suiting IPO subscribed 12.13x.
